ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. MGNX, a biopharmaceutical firm centered on growing, manufacturing and commercializing progressive monoclonal antibody-based therapeutics for the therapy of most cancers, as we speak introduced that the Firm will launch its monetary outcomes for the fourth quarter and full 12 months of 2024 after the market closes on Thursday, March 20, 2025. MacroGenics will host a convention name to debate the monetary outcomes and up to date company progress on Thursday, March 20, 2025, at 4:30 pm ET
Convention Name Info
To take part through phone, please register upfront through this link. Upon registration, all phone contributors will obtain a affirmation electronic mail detailing the way to be a part of the convention name, together with the dial-in quantity together with a singular passcode and registrant ID that can be utilized to entry the decision. The listen-only webcast of the convention name could be accessed underneath “Occasions & Displays” within the Investor Relations part of the Firm’s web site at http://ir.macrogenics.com/events.com. A recorded replay of the webcast might be obtainable shortly after the conclusion of the decision and archived on the Firm’s web site for 30 days following the decision.
About MacroGenics, Inc.
MacroGenics (the Firm) is a biopharmaceutical firm centered on discovering, growing, manufacturing and commercializing progressive monoclonal antibody-based therapeutics for the therapy of most cancers. The Firm generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based know-how platforms, which have applicability throughout broad therapeutic domains. The mixture of MacroGenics’ know-how platforms and protein engineering experience has allowed the Firm to generate promising product candidates and enter into a number of strategic collaborations with world pharmaceutical and biotechnology corporations. For extra info, please see the Firm’s web site at www.macrogenics.com. MacroGenics and the MacroGenics emblem are emblems or registered emblems of MacroGenics, Inc.
Contacts: Jim Karrels, Senior Vice President, CFO 1-301-251-5172 [email protected] Argot Companions 1-212-600-1902 [email protected]
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
